Kyle Bailey

Head of Commercial Operations, Rare Disease Business Unit at Ipsen Pharmaceuticals

Speaker

Kyle Bailey serves as Head of Commercial Operations for the U.S. Rare Disease Franchise at Ipsen, where he leads strategic initiatives across analytics, operations, and learning & development to drive commercial excellence. With extensive experience in sales, value and access strategy, and operations leadership, Kyle has built and led high-performing teams that translate strategy into measurable impact. His career spans multiple rare disease therapeutic areas, with a focus on optimizing launch readiness, field enablement, and operational performance. He is passionate about advancing innovative therapies and fostering collaboration across functions to deliver meaningful outcomes for patients.